Company Overview of Merck Research Laboratories
Merck Research Laboratories discovers and develops medicines for cancer and neurodegenerative disorders. The company was founded in 2004 and is based in Boston, Massachusetts. Merck Research Laboratories operates as a subsidiary of Merck & Co. Inc.
33 Avenue Louis Pasteur
Boston, MA 02115
Founded in 2004
Key Executives for Merck Research Laboratories
Senior Vice President and Franchise Head of Immunology Respiratory & Endocrine
Senior Vice President and Franchise Head of Diabetes & Obesity
Senior Vice President and Head of Franchise
Compensation as of Fiscal Year 2015.
Merck Research Laboratories Key Developments
TESARO and Merck Collaborate for Phase I/II Breast and Ovarian Cancer Trial
Jun 11 15
TESARO, Inc. and Merck have collaborated to evaluate the combination of TESARO's niraparib plus Merck's anti-PD1 therapy, KEYTRUDA, in a Phase I/II clinical trial in patients with breast and ovarian cancers. This trial is planned to evaluate the preliminary safety and efficacy of niraparib plus KEYTRUDA in patients with triple negative breast cancer or ovarian cancer. This trial will be conducted by TESARO and Merck, through a subsidiary, and is expected to begin by the end of 2015.
Merck Research Laboratories Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 08:40 AM
May 17 15
Merck Research Laboratories Presents at Sachs Immuno-Oncology: BD&L and Investment Forum, May-29-2015 08:40 AM. Venue: Hyatt Chicago Magnificent Mile, Chicago, Illinois, United States. Speakers: Ji Li, Vice President, Business Development and Licensing.
Merck Research Laboratories Presents at ChinaBio Partnering Forum 2015, Apr-15-2015 09:30 AM
Apr 13 15
Merck Research Laboratories Presents at ChinaBio Partnering Forum 2015, Apr-15-2015 09:30 AM. Venue: Kerry Hotel, Pudong, Shanghai, China. Speakers: Yongkui Sun, Scout, Greater China, Business Development and Licensing.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries